CAS number index
Every CAS Registry Number in our catalogue, sorted numerically. Paste a CAS No. into the search bar to jump straight to the product.
| CAS No. | Substance | Grades |
|---|---|---|
| 20287-95-0 | 17-Alpha-Hydroxy-3,20-dioxopregn-4-en-21-al | 1 |
| 20287-97-2 | 21-Dehydrocorticosterone | 1 |
| 20289-27-4 | 7-Benzyloxyindole | 1 |
| 20290-48-6 | Dibenzo[b,f][1,4]thiazepin-11(10H)-one, 5-oxide | 1 |
| 20290-75-9 | Stearidonic Acid | 1 |
| 20297-37-4 | Vildagliptin Carbonitrile Impurity | 1 |
| 20312-37-2 | (R)-2-Hydroxy-4-methylpentanoic acid | 1 |
| 20315-46-2 | Beta Ergocryptine | 1 |
| 20316-62-5 | Tiliroside | 1 |
| 20324-51-0 | 2-Chloro-6-mercapto-Benzoicacid, extra pure >95% | 1 |
| 20325-40-0 | o-Dianisidine dihydrochloride, ≥98% | 1 |
| 20328-15-8 | Ethyl 3-methylisoxazole-4-carboxylate | 1 |
| 20328-96-5 | Antimony nitrate | 1 |
| 20344-49-4 | Iron(III) oxide, hydrated | 1 |
| 20367-38-8 | Albendazole EP Impurity G | 1 |
| 20380-11-4 | 27-Hydroxycholesterol | 1 |
| 20401-12-1 | 17-O-Methyl Boldenone | 1 |
| 20402-55-5 | Norgestrel EP Impurity H | 1 |
| 20402-61-3 | Norgestrel EP Impurity C | 1 |
| 20402-62-4 | Levonorgestrel EP Impurity I | 1 |
| 20403-06-9 | Samarium(III) hydroxide, hydrate, 99% | 1 |
| 20405-64-5 | Copper(I) selenide, 99.95% trace metals basis | 1 |
| 20410-98-4 | 6a-Naltrexol | 1 |
| 20412-39-9 | 2-Methylbutyl chloroformate | 1 |
| 20423-99-8 | Prednisolone Acetate EP Impurity D | 1 |
| 20430-18-6 | 2-Methyl-2-(p-tolyl)propanoic Acid | 1 |
| 20439-47-8 | (1R,2R)-(−)-1,2-Diaminocyclohexane, 98% | 1 |
| 20440-94-2 | 4-Methoxy-N-(4-methoxyphenyl)-N-phenylaniline, 95% | 1 |
| 20455-68-9 | Dibenzylamine hydrochloride | 1 |
| 20469-65-2 | 1-Bromo-3,5-dimethoxybenzene, 97% | 1 |
| 20488-28-2 | Vildagliptin Impurity 8 | 1 |
| 20496-01-9 | 4-Chlorobutanoic anhydride | 1 |
| 20511-12-0 | 2-Amino-5-iodopyridine, 98% | 1 |
| 20513-09-1 | 8-Methyl-8-azabicyclo[3.2.1]oct-6-en-3-ol | 1 |
| 20526-97-0 | Azelastine EP Impurity E | 1 |
| 20529-23-1 | 3-(4-(2-Methoxyphenyl)piperazin-1-yl)propan-1-amine | 1 |
| 20535-28-8 | 2-Deoxy-D-erythro-pentopyranosyl Chloride Bis(4-methylbenzoate) (Mixture of α/β isomers) | 1 |
| 20535-83-5 | 6-O-Methylguanine | 1 |
| 20537-88-6 | Amifostine | 1 |
| 20542-97-6 | Ferric Borate | 1 |
| 20548-54-3 | Calcium sulphide | 1 |
| 20554-84-1 | Parthenolide | 1 |
| 20559-16-4 | Myristoyl L-alpha-lysolecithin | 1 |
| 20559-55-1 | Oxibendazole | 1 |
| 20562-02-1 | alpha-Solanine | 1 |
| 20562-03-2 | Alpha-Chaconine | 1 |
| 20570-96-1 | Benzylhydrazine dihydrochloride, 97% | 1 |
| 20587-29-5 | Methyl 4-methyl 2-nitrobenzoate | 1 |
| 20592-42-1 | Estrone Enol Diacetate | 1 |
| 20592-45-4 | 17-alpha-Acetoxy-4-chloroprogesterone | 1 |
| 20594-83-6 | Nalbuphine | 1 |
| 20596-93-4 | Uranyl magnesium acetate | 1 |
| 20619-12-9 | Chlorphenamine EP Impurity C | 1 |
| 20623-13-6 | Nitritocobalamin | 1 |
| 20624-25-3 | Disulfiram EP Impurity B (Sodium Salt) | 3 |
| 20624-87-7 | 3-Chloro-4,5-dimethoxybenzoic acid | 1 |
| 20627-44-5 | Perazine Sulfoxide | 1 |
| 20633-84-5 | Luteolin 7-O-rutinoside | 1 |
| 20634-12-2 | Tetraammineplatinum(II) nitrate, ≥50% Pt basis | 2 |
| 20640-68-0 | DL-Phenylmercapturic Acid | 1 |
| 20661-21-6 | Indium hydroxide nanopowder, APS 20-70 nm, 99.99% | 1 |
| 20662-14-0 | Scandium chloride, 99.99% | 1 |
| 20662-53-7 | Benperidol EP Impurity A | 1 |
| 20666-60-8 | Uracil-1,3 D2 | 1 |
| 20667-05-4 | 2-Methylpentane-1,2-diol | 1 |
| 20667-12-3 | Silver oxide, ≥99% | 5 |
| 20675-51-8 | (+/-)-Cannabichromene | 1 |
| 20684-06-4 | Bamifylline Hydrochloride | 1 |
| 20689-96-7 | Rivaroxaban Nitroso Impurity 2 | 1 |
| 20691-84-3 | m-Methyl red, 98% | 1 |
| 20702-77-6 | Neohesperidine dihydrochalcone, 98% | 1 |
| 20708-81-0 | 17-epi-Nandrolone | 1 |
| 20721-48-6 | S,S′-Dimethylxanthogenethylenebisdithiocarbamate | 1 |
| 20730-07-8 | Pyridine-2,5-dicarbonitrile | 1 |
| 20731-62-8 | Thulium(III) sulphate, 99.99% | 1 |
| 20744-51-8 | Deoxystreptamine Kanosaminide | 1 |
| 20747-49-3 | (-)-Neomenthol | 1 |
| 20748-12-3 | Methylphenidate EP Impurity B | 1 |
| 20752-33-4 | (1R,2S,5S)-2-Isopropyl-5-methylcyclohexan-1-ol | 1 |
| 20752-34-5 | (1R,2R,5R)-2-Isopropyl-5-methylcyclohexan-1-ol | 1 |
| 20752-56-1 | Magnesium tartrate | 1 |
| 20762-60-1 | Potassium azide, ≥99.9% | 1 |
| 20765-98-4 | Rhodium(III) chloride, hydrate, crystalline, 99.9% | 2 |
| 20769-85-1 | 2-Bromoisobutyryl bromide, extra pure >98% | 1 |
| 20776-48-1 | 2-Amino-6-bromobenzoic acid, 99% | 1 |
| 20776-50-5 | 4-Bromoanthranilic acid, 97% | 1 |
| 20780-53-4 | R(+)STYRENE OXIDE [(R)-2-Phenyloxirane], extra pure >98% | 1 |
| 20780-54-5 | (S)-Styrene oxide | 2 |
| 20813-76-7 | In0sine-5-monophosphate disodium salt dihydrate, EP | 2 |
| 20814-06-6 | Europium (III) Sulphate | 1 |
| 20816-12-0 | Osmic acid, 99.9% | 3 |
| 20826-04-4 | 5-Bromonicotinic acid, LR | 2 |
| 20830-75-5 | Digoxin | 1 |
| 20830-81-3 | Daunorubicin | 1 |
| 20831-76-9 | Gentiopicrin | 1 |
| 20845-01-6 | Hydroxylamine Phosphate, for synthesis | 1 |
| 20850-43-5 | Piperonyl chloride | 1 |
| 20850-49-1 | Verapamil EP Impurity K | 1 |
| 20859-02-3 | L-tert-Leucine, 99% | 1 |
| 20869-27-6 | Lactulose EP Impurity A | 1 |
| 20880-67-5 | Phenoxymethylpenicillin EP Impurity D | 1 |
| 20880-92-6 | Topiramate EP Impurity A | 1 |
| 20893-30-5 | 2-Thiopheneacetonitrile, 97% | 1 |
| 20897-91-0 | Alprostadil EP Impurity D | 1 |
| 20902-45-8 | D-Penicillamine Disulfide | 1 |
| 20925-64-8 | Ivabradine Impurity 51 | 1 |
| 20927-53-1 | Diazepam EP Impurity E | 1 |
| 20927-55-3 | 7-Chloro-5-phenyl-1H-benzo[e][1,4]diazepine-2,3-dione | 1 |
| 20959-33-5 | 7-Methylheptadecane | 1 |
| 20962-92-9 | N-Allylphenothiazine | 1 |
| 20972-07-0 | Campesteryl Ferulate | 1 |
| 20980-22-7 | Buspirone EP Impurity A | 1 |
| 20989-17-7 | L-Phenylglycinol | 1 |
| 21002-80-2 | Testosterone-2,2,4,6,6-D5 | 1 |
| 21003-46-3 | Alprostadil EP Impurity F | 1 |
| 21018-84-8 | Amarogentin | 1 |
| 21041-10-1 | Dihydronarwedine | 1 |
| 21041-93-0 | Cobalt(II) hydroxide, 95% | 1 |
| 21067-16-3 | Glycerol 2-lactate | 1 |
| 21080-92-2 | Ticarcillin EP Impurity C | 1 |
| 21087-64-9 | Metribuzin | 1 |
| 21093-14-1 | rac-Epinephrine-3-O-sulfate sodium salt | 1 |
| 21093-18-5 | Epinephrine Sulfate | 1 |
| 21098-11-3 | Buspirone EP Impurity L | 1 |
| 21108-81-6 | Imidazole-1-sulfonic Acid | 1 |
| 21109-95-5 | Barium sulphide | 2 |
| 21122-68-9 | Mefenamic Acid EP Impurity B | 1 |
| 21133-52-8 | Lycoramine | 1 |
| 21138-24-9 | L-Inosine | 1 |
| 21141-35-5 | 8-Methoxyquinoline-2-carboxylic acid | 1 |
| 21147-23-9 | Methyl 2-(4-Hydroxybenzoyl)Benzoate | 1 |
| 21165-77-5 | Glibenclamide EP Impurity B | 1 |
| 21169-71-1 | Isoxazole-5-carboxylic acid, 97% | 1 |
| 21172-41-8 | 3-(Trifluoromethyl)benzenepropanal | 1 |
| 21172-43-0 | Cinacalcet Impurity 7 | 1 |
| 21187-98-4 | Gliclazide | 2 |
| 21190-87-4 | 6-Bromopicolinic Acid | 1 |
| 21193-38-4 | 2-((2,5-Dimethylphenyl)amino)benzoic Acid | 1 |
| 21221-29-4 | Ethynyl Estradiol 17-Acetate | 1 |
| 21236-97-5 | 6-Amino-3-methyluracil | 1 |
| 21237-84-3 | 6,8-Dibromo-3-cyclohexyl-3,4-dihydro-2(1H)-quinazolinone | 1 |
| 21245-02-3 | Padimate O | 1 |
| 21253-58-7 | 4-((2,4-Diaminopyrimidin-5-yl)methyl)-2,6-dimethoxyphenol | 1 |
| 21255-69-6 | O-Desmethylangolensin | 1 |
| 21256-18-8 | Oxaprozin | 1 |
| 21259-20-1 | T-2 Toxin | 1 |
| 21269-37-4 | Tiopronin Disulfide | 1 |
| 21282-08-6 | L-Pyroglutamyl Alanine | 1 |
| 21285-46-1 | trans-2,3-Dibromo-2-butene-1,4-diol, 97% | 1 |
| 21286-54-4 | (1S)-(+)-10-Camphorsulfonyl chloride, 97% | 1 |
| 21288-34-6 | Ketoprofen EP Impurity I | 1 |
| 21293-29-8 | (+)-cis,trans-Abscisic Acid | 1 |
| 21302-43-2 | 5-Amino-8-hydroxyquinoline dihydrochloride, 95% | 1 |
| 21312-10-7 | Sulfamethoxazole EP Impurity A | 1 |
| 21320-31-0 | N2,N2,6-Trimethyl-1,3,5-triazine-2,4-diamine | 1 |
| 21324-39-0 | Sodium hexafluorophosphate, 98% | 2 |
| 21324-99-2 | 2-(Dibenz[b,e]oxepin-11(6H)-ylidene)acetaldehyde | 1 |
| 21343-40-8 | 25-Hydroxyvitamin D2 | 1 |
| 21351-79-1 | Caesium hydroxide 50%w/w solution, LR 50% | 2 |
| 21369-64-2 | Hexyllithium solution, 2.5 M in hexane | 1 |
| 21386-95-8 | 4-Amino-5-chloro-2-hydroxybenzoic acid | 1 |
| 21388-17-0 | Naproxen EP Impurity J | 1 |
| 21409-25-6 | Diphenyl methoxy acetic acid | 1 |
| 21411-53-0 | Virginiamycin M1 | 1 |
| 21414-41-5 | Glucoraphanin | 1 |
| 21436-03-3 | (1S,2S)-(+)-1,2-Diaminocyclohexane, 98% | 1 |
| 21436-98-6 | Lidocaine EP Impurity A Hydrochloride | 1 |
| 21446-46-8 | (S)-1-Methylnicotinium Iodide | 1 |
| 21462-39-5 | Clindamycin hydrochloride, 97% | 1 |
| 21472-33-3 | 5-Benzoyl-1,3-dihydro-2H-benzimidazol-2-one | 1 |
| 21473-01-8 | 2-Naphthylmagnesium bromide solution 0.5 M in THF | 1 |
| 21480-44-4 | (1S,2S)-1-(m-Hydroxyphenyl)-2-amino-1-propanol | 1 |
| 21498-08-8 | Lofexidine Hydrochloride | 1 |
| 21501-24-6 | N-[4-[(4-Aminophenyl)sulfonyl]phenyl]formamide | 1 |
| 21508-50-9 | Levonorgestrel EP Impurity I | 1 |
| 21514-87-4 | Ethyl eosin | 1 |
| 21516-68-7 | Monascin | 1 |
| 21524-34-5 | 2,4,6-Triisopropylbromobenzene, 97% | 1 |
| 21535-43-3 | Epinastine Chloroacetamide Impurity | 1 |
| 21535-47-7 | Mianserin Hydrochloride | 1 |
| 21542-82-5 | Sulfasalazine EP Impurity I | 1 |
| 21547-96-6 | Linagliptin (Stage-I) | 1 |
| 21548-73-2 | Silver sulphide, 98% | 1 |
| 21571-08-4 | Methyl (2-aminoethyl)carbamimidothioate | 1 |
| 21593-23-7 | Cephapirin | 1 |
| 21593-77-1 | S-Allyl-L-cysteine | 1 |
| 21606-04-2 | 1-Methyl-3-nitrophthalate | 1 |
| 21615-34-9 | 2-Methoxybenzoyl chloride, 97% | 1 |
| 21616-46-6 | Fosphenytoin Impurity D | 1 |
| 21617-12-9 | 4,8-Dichloroquinoline | 1 |
| 21617-18-5 | 4,5-Dichloroquinoline | 1 |
| 21626-43-7 | Flupirtine Impurity C | 1 |
| 21636-51-1 | Pyridine-3,5-diyldimethanol | 1 |
| 21637-25-2 | Rutoside Trihydrate EP Impurity A | 1 |
| 21642-86-4 | 4'-Hydroxyatropine | 1 |
| 21645-51-2 | Aluminium hydroxide, 76.5% min | 3 |
| 21651-19-4 | Stannous oxide | 2 |
| 21652-58-4 | Heptadecafluoro-1-decene | 1 |
| 21653-40-7 | Nα-Benzoyl-L-arginine 4-nitroanilide hydrochloride ≥99% (TLC), suitable for substrate for trypsin | 1 |
| 21655-48-1 | cis-2,6-Dimethylpiperazine, 98% | 1 |
| 21663-61-6 | 2,5-Dichlorobenzonitrile, 98% | 1 |
| 21675-47-8 | 2-Ketogulonic acid | 1 |
| 21679-14-1 | Fludarabine Phosphate EP Impurity E | 1 |
| 21679-31-2 | Chromium(III) acetylacetonate, 97% | 1 |
| 21679-46-9 | Cobalt(III) acetylacetonate, 98% | 1 |
| 21704-80-3 | Tryptophan - Impurity G | 1 |
| 21709-18-2 | N-(2,6-Dichlorophenyl)-carbonimidic Dichloride | 1 |
| 21709-90-0 | Propionyl glycine | 1 |
| 21715-46-8 | Etifoxine | 1 |
| 21715-90-2 | N-Hydroxy-5-norbornene-2,3-dicarboxylic acid imide, 97% | 1 |
| 21729-98-6 | Methylcyanocarbamate | 1 |
| 21732-17-2 | Tetrazolylacetic Acid | 1 |
| 21736-83-4 | Spectinomycin Dihydrochloride | 1 |
| 21737-58-6 | Oxcarbazepine EP Impurity C | 1 |
| 21739-92-4 | 5-Bromo-2-Chlorobenzoic Acid | 2 |
| 21739-93-5 | 2-Bromo-5-chlorobenzoic acid, 98% | 1 |
| 21743-75-9 | 1H-Tetrazole-5-acetic acid, 96% | 1 |
| 21747-46-6 | Viridiflorene | 1 |
| 21755-34-0 | Ethyl imidazo[1,2-a]pyridin-2-ylacetate | 1 |
| 21794-55-8 | Epirubicin EP Impurity B | 1 |
| 21800-83-9 | Levonorgestrel EP Impurity L | 1 |
| 21801-99-0 | 6-Chloro-N,4-dimethyl-4-phenyl-4H-3,1-benzoxazin-2-amine | 1 |
| 21829-25-4 | Nifedipine | 2 |
| 21829-28-7 | Nitrendipine EP Impurity C | 1 |
| 21835-01-8 | Ethylcyclopentenolone, 97% | 1 |
| 21850-44-2 | Bis(2,3-dibromopropoxy)tetrabromobisphenol A | 1 |
| 21852-32-4 | 4-(Bromomethyl)-1,2-dimethoxybenzene | 1 |
| 21856-89-3 | 6-Hydroxyhexan-2-one | 1 |
| 21881-45-8 | Estradiol valerate EP Impurity B | 1 |
| 21881-77-6 | Lercanidipine Dimethyl Ester Impurity | 1 |
| 21881-78-7 | Nisoldipine EP Impurity B | 1 |
| 21887-64-9 | Boc-ornithine, 99% | 1 |
| 21898-19-1 | Clenbuterol HCl | 1 |
| 21900-52-7 | 5-Bromo-2-chloro-benzoyl chloride | 1 |
| 21906-39-8 | (3-Trifluoromethyl)phenylacetone | 1 |
| 21908-53-2 | Mercuric oxide, red, 99% | 4 |
| 21912-23-2 | 1,3-Dibromo-5,7-dimethyladamantane | 1 |
| 21912-49-2 | Brombuterol Hydrochloride | 1 |
| 21928-51-8 | 5-Bromo-1,2,3-trichlorobenzene, 98% | 1 |
| 21931-53-3 | Uridine 5'-Diphosphate Sodium Salt | 1 |
| 21938-24-9 | 5-(Dimethylamino)pentanal diethyl acetal | 1 |
| 21940-36-3 | Neohesperidin Dihydrochalcone EP Impurity F | 1 |
| 21940-45-4 | 6-Dehydrocortisol Acetate | 1 |
| 21945-86-8 | Orphenadrine EP Impurity E | 1 |
| 21945-88-0 | Methyl Orphenadrine | 1 |
| 21947-32-0 | Boc-Nle-OH·DCHA, ≥98% (TLC) | 1 |
| 21956-47-8 | (R)-(-)-Littorine | 1 |
| 21962-45-8 | 4-Cyano-2-methoxybenzaldehyde | 1 |
| 21963-27-9 | 4-Propylfuran-2(5H)-one | 1 |
| 21967-41-9 | Baicalin, 95%+ | 1 |